Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma by Müller, Anne et al.








Distinct gene expression profiles characterize the histopathological stages of
disease in Helicobacter-induced mucosa-associated lymphoid tissue
lymphoma
Müller, Anne ; O’Rourke, J ; Grimm, J ; Guillemin, K ; Dixon, M F ; Lee, A ; Falkow, S
Abstract: Long-term colonization of humans with Helicobacter pylori can cause the development of gastric
B cell mucosa-associated lymphoid tissue lymphoma, yet little is known about the sequence of molecular
steps that accompany disease progression. We used microarray analysis and laser microdissection to
identify gene expression profiles characteristic and predictive of the various histopathological stages in
a mouse model of the disease. The initial step in lymphoma development is marked by infiltration of
reactive lymphocytes into the stomach and the launching of a mucosal immune response. Our analysis
uncovered molecular markers of both of these processes, including genes coding for the immunoglobulins
and the small proline-rich protein Sprr 2A. The subsequent step is characterized histologically by the
antigen-driven proliferation and aggregation of B cells and the gradual appearance of lymphoepithelial
lesions. In tissues of this stage, we observed increased expression of genes previously associated with
malignancy, including the laminin receptor-1 and the multidrug-resistance channel MDR-1. Finally, we
found that the transition to destructive lymphoepithelial lesions and malignant lymphoma is marked by
an increase in transcription of a single gene encoding calgranulin AMrp-8.
DOI: https://doi.org/10.1073/pnas.242741699





Müller, Anne; O’Rourke, J; Grimm, J; Guillemin, K; Dixon, M F; Lee, A; Falkow, S (2003). Distinct gene
expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-
associated lymphoid tissue lymphoma. Proceedings of the National Academy of Sciences of the United
States of America (PNAS), 100(3):1292-1297.
DOI: https://doi.org/10.1073/pnas.242741699
Distinct gene expression profiles characterize the
histopathological stages of disease in Helicobacter-
induced mucosa-associated lymphoid tissue lymphoma
Anne Mueller*†, Jani O’Rourke‡, Jan Grimm§, Karen Guillemin¶, Michael F. Dixon, Adrian Lee‡, and Stanley Falkow*
*Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5402; ‡School of Microbiology and
Immunology, University of New South Wales, Sydney 2052, Australia; §Rinat Neuroscience Corporation, Palo Alto, CA 94304; ¶Institute of
Molecular Biology, University of Oregon, Eugene, OR 97403-1229; and Department of Histopathology, University of Leeds,
Leeds LS9 7TF, United Kingdom
Contributed by Stanley Falkow, December 5, 2002
Long-term colonization of humans with Helicobacter pylori can cause
the development of gastric B cell mucosa-associated lymphoid tissue
lymphoma, yet little is known about the sequence of molecular steps
that accompany disease progression. We used microarray analysis
and laser microdissection to identify gene expression profiles char-
acteristic and predictive of the various histopathological stages in a
mouse model of the disease. The initial step in lymphoma develop-
ment is marked by infiltration of reactive lymphocytes into the
stomach and the launching of a mucosal immune response. Our
analysis uncovered molecular markers of both of these processes,
including genes coding for the immunoglobulins and the small pro-
line-rich protein Sprr 2A. The subsequent step is characterized histo-
logically by the antigen-driven proliferation and aggregation of B
cells and the gradual appearance of lymphoepithelial lesions. In
tissues of this stage, we observed increased expression of genes
previously associated with malignancy, including the laminin recep-
tor-1 and the multidrug-resistance channel MDR-1. Finally, we found
that the transition to destructive lymphoepithelial lesions and malig-
nant lymphoma is marked by an increase in transcription of a single
gene encoding calgranulin AMrp-8.
Colonization of the human stomach by Helicobacter pylori iscausally associated with gastritis, peptic ulcer disease, and two
gastric malignancies, adenocarcinoma and B cell mucosa-associated
lymphoid tissue (MALT) lymphoma (1, 2). Direct antigenic stim-
ulation by H. pylori results in the proliferation of lymphocytes and
the formation of lymphoid follicles in the gastric mucosa, consti-
tuting the so-called MALT (3–5). Gastric MALT lymphoma is
believed to arise from neoplastic B cell clones in the marginal zone
of the follicle that invade the adjacent epithelium (6), a process
marked histologically by the appearance of lymphoepithelial lesions
(LELs). Malignant lymphomas are distinguished from precancer-
ous MALT by the appearance of atypical centrocyte-like cells,
multiple destructive LELs, and extension of the infiltrate into the
submucosa (reviewed in ref. 7).
Evidence for the causal link between infection and tumor de-
velopment comes from epidemiological studies showing a high
prevalence of the bacterium in MALT lymphoma patients (8–10).
Remarkably, eradication of the bacterium by antibiotic treatment
leads to the complete regression of tumors in the majority of
patients (6, 11, 12).** Consequently, antimicrobial therapy has
largely replaced gastric resection as the first line of MALT lym-
phoma treatment (13).
The clinical and histopathological characteristics of human
MALT lymphomas, including the antibiotic-induced regression of
the disease, can be mimicked in BALBc mice by long-term
infection with several gastric Helicobacter species (14–16). The
murine model provides a unique experimental system to study the
progression of the disease from the early immune responses to fully
developed malignant marginal zone lymphomas. To increase our
knowledge of Helicobacter-induced lymphomagenesis, we have
used murine cDNA microarrays and laser microdissection to iden-
tify molecular markers of the histopathological stages of the disease
and to define the cellular origin of the transcriptional responses. We
show here that the disease follows a molecular progression, and we
have identified a collection of genes whose expression level is
predictive of disease stage.
Methods
Mouse Infections and RNA Extraction. Groups of specific pathogen-
free BALBc mice were infected with either Helicobacter heilman-
nii (a Mandrill monkey isolate), Helicobacter felis (ATCC 49179
strain CS1), or H. pylori SSI (ref. 17). Uninfected age-matched
animals served as controls. The animals were killed at various time
intervals after inoculation (12, 18, 20, 22, and 24 mos), one-half of
the stomach was fixed in paraformaldehyde for histopathological
examination, and the remainder was snap frozen at 80°C.
Hematoxylineosin-stained sections were coded and examined
blindly for the presence of lymphocytic infiltrates and LEL. These
features were graded on a 0 to 3 point scale by using the following
criteria. Lymphocytic infiltration: 0, no change; 1, single or few
small aggregates of lymphocytes; 2, multiple multifocal large lym-
phoid aggregates or follicles; 3, extensive multifocal lymphocytic
infiltration often extending through depth of mucosa resulting in
distortion of the epithelial surface. LELs: 0, no LELs; 1, early or
single LELs; 2, multiple well formed LELs, 3, multiple LELs
resulting in extensive destruction of the epithelium.
RNA extractions from the remaining half of every stomach were
performed by using Trizol reagent according to the manufacturer’s
instructions (Invitrogen Life Technologies). Total RNA was then
further purified by using Qiagen (Chatsworth, CA) RNeasy kits.
RNA Labeling and Hybridization. Detailed protocols for probe syn-
thesis and DNA microarray hybridization are given at http:
cmgm.stanford.edupbrownprotocolsindex.html. In short, 40 g
of total RNA was used for single-stranded cDNA probe synthesis
incorporating aminoallyl-dUTP, which was subsequently coupled
with either Cy3 (for the reference sample) or Cy5 (for the exper-
imental sample). Experimental and references samples were com-
bined and hybridized at 65°C in 3.4 SSC and 0.3% SDS to a
38,000-element spotted mouse cDNA microarray. The reference
for all arrays used in this study consisted of pooled cDNA extracted
from stomachs of age-matched uninfected control animals (10
animals per time point).
Abbreviations: MALT, mucosa-associated lymphoid tissue; LEL, lymphoepithelial lesion;
SAM, significance analysis of microarrays.
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**This finding could suggest that MALT lymphomas are not true malignancies. On the basis
of the fact that these tumors show uncontrolled growth as well as a (low) tendency to
local and systemic dissemination (reviewed in ref. 7) and the disease is potentially lethal
if left untreated, we will use the term ‘‘malignancy’’ here for both the human disease and
the parallel disease described in the murine model.
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Laser Microdissection and RNA Amplification. Ten-micrometer cryo-
sections of mouse stomachs were mounted on polyester membrane
slides (Leica, Deerfield, IL) and a quick staining was performed:
after fixation in 75% ethanol for 30 s, the slides were dipped in
distilled water and stained for 1 min with Histogene staining
solution (Arcturus, Mountain View, CA). The slides were washed
in distilled water, dehydrated for 30 s in 75%, 95%, and 100%
ethanol, respectively, and dried at room temperature. Mucosal
tissue and lymphocytic aggregates were isolated by laser microdis-
section with a Leica AS laser microdissection system. Total RNA
was isolated with the Picopure kit (Arcturus) and amplified by two
rounds of T7-based linear amplification with the Riboamp kit
(Arcturus) according to the manufacturer’s protocol.
Data Analysis. Arrays were scanned by using a GenePix 4000A
scanner and images analyzed with GENEPIX PRO software (Axon
Instruments, Foster City, CA). Microarray data were stored in the
Stanford Microarray Database (18). Data were filtered with respect
to spot quality (spots with regression correlations 0.6 were
omitted) and data distribution (genes whose log2 of redgreen
normalized ratio is more than two standard deviations away from
the mean in at least three arrays were selected) before clustering.
Only genes for which information was available for more than 80%
of arrays were included. Data were log2 transformed and analyzed
by using CLUSTER and TREEVIEW (19). Statistical analysis was done
by using the significance analysis of microarrays algorithm (SAM,
ref. 20). Data from all of the arrays used in this paper are available
at http:genome-www4.stanford.eduMicroArraySMD.
Results and Discussion
To identify the most virulent Helicobacter species in the mouse,
groups of BALBc mice were infected for up to 24 mos with either
H. pylori, H. felis, or H. heilmannii, the latter also being associated
with MALT lymphoma in humans (21). Their stomachs were
examined histopathologically (Fig. 1). Although the lesions (Fig.
1A) induced by the three species were indistinguishable qualita-
tively, H. heilmannii triggered the most severe response in the
highest proportion of infected animals (Fig. 1B). On the basis of this
result, we decided to follow disease progression in H. heilmannii-
infected mice and chose the time points 12, 18, and 24 mos
postinfection for further analysis. Total RNA was extracted from
the stomachs of infected animals and of a cohort of age-matched
uninfected control animals. The corresponding cDNA was labeled
with the fluorescent dye Cy5, mixed with Cy3-labeled reference
Fig. 1. Histopathological and CLUSTER analysis of BALBc mice infected with Helicobacter. (A and B) Mice were infected up to 24 mos with H. pylori, H. felis,
or H. heilmannii. One-half of each stomach was fixed, stained with hematoxylineosin, and examined for the presence of LELs. (A) Cross section of a
H. heilmannii-infected stomach (Upper) displaying marked lymphocytic infiltration (dark-blue staining) and partial destruction of gastric gland epithelium
(Inset). (Lower) Cross section of an age-matched uninfected stomach. (B) Virulence comparison of the three Helicobacter species. Infected stomachs were graded
on a 0–3 scale, as described in Methods. The percentage of animals with moderate (grade 2) or severe (grade 3) pathology is indicated. Note: at 18 mos
postinfection (p.i.), the majority of animals show severe signs of illness, and thus group sizes dwindle due to infection-induced and age-related deaths (only 80%
of uninfected and 50–70% of infected animals survive for 24 mo, depending on the infecting Helicobacter species). This finding explains the increased percentage
of animals with severe LELs at 18 mos p.i. compared with the later time points. (C) Overview of the pathology observed in all 41 animals used in this study. Thirteen
control (uninfected) animals and 28 H. heilmannii-infected animals (contr and Hh) from three different time points [12, 18, and 22 mos (12M, 18M, 22M)] were
classified on a 0–3 scale with respect to the presence of lymphocytic infiltration and LELs, as described in Methods. An overall pathology classification was assigned
to every animal on the basis of these grades. The animals were assembled into four groups, as indicated by the color coding. Animals with mild pathology are
depicted in green; animals with moderate and severe pathology are depicted in black; and animals with a lymphoma diagnosis are depicted in red. Control
animals are shown in blue. The color code is maintained throughout the paper. (D) The dendrogram reveals the relatedness of the gene expression profiles of
the mice as determined by CLUSTER analysis. The data were filtered with respect to spot quality and data distribution before clustering.










sample, and hybridized to a spotted 38,000-element murine cDNA
microarray that contains features derived from the RIKEN (22)
and NIA (23) mouse clone sets.
A hierarchical clustering algorithm was used to group genes and
experimental samples in an ‘‘unsupervised’’ fashion on the basis of
similarities of gene expression (19). The relationships between the
experimental samples are summarized in a dendrogram (Fig. 1D).
The resulting clusters were subsequently compared with the stom-
ach pathology of the corresponding mice (Fig. 1C), which was
histologically classified on a 0–3 scale. All but three control samples
(blue) cluster separately from the infected specimens and form a
distinct branch of the dendrogram (Fig. 1D). Infected samples
displaying mild pathology (green) segregate from moderate or
severe pathology samples (black and red), with two exceptions. In
contrast, the specimens histologically classified as lymphomas due
to the presence of groups of centrocyte-like cells invading the
epithelium (red) failed to form a distinct cluster but were inter-
spersed among the other moderate and severe pathology samples.
The differences in gene expression between samples with severe
lymphoid hyperplasia and those with true malignancy are therefore
not sufficient to drive the clustering. This finding argues against one
definitive transforming event and in favor of a continuum of which
malignant lymphomas represent the end point.
Because the hierarchical clustering segregated uninfected from
infected samples, we sought to identify genes whose expression was
characteristic and predictive of infection. We used a strategy
referred to as ‘‘supervised clustering’’ (24), which allowed us to
identify a limited set of ‘‘signature genes’’ for the different stages of
pathology. A two-group unpaired t test was performed on the log2
redgreen normalized ratios of infected vs. uninfected samples, and
the 250 most differentially expressed genes (P values 0.001) were
selected and subjected to hierarchical clustering. This procedure
revealed clusters of genes that were up- or down-regulated specif-
ically in the infected group (overview in Fig. 2A). The gene cluster
in Fig. 2B shows the genes up-regulated in the infected stomachs,
and selected genes are designated (complete gene clusters are
published as Fig. 5).
The up-regulated genes fall into two major groups: first, there are
typical lymphocyte signature genes such as those coding for the Ig
genes, the tetraspanin family member CD53, TNF receptor 5 (also
called CD40, a marker for mature B cells), and integrin 7, a
component of the mucosal homing receptor of B cells. Up-
regulation of these genes confirms the presence of lymphocytes in
the lesions (reviewed in ref. 25). The up-regulation of several genes
encoding components of the major histocompatibility complex
(MHC) is of interest because MHC class II molecules reportedly
mediate H. pylori binding to target cells (26). Another lymphocyte
surface molecule in this cluster, CD52, is the target of CAMPATH-
1H, an antibody of increasing clinical importance in the treatment
of lymphoproliferative disorders (reviewed in ref. 27). The other
major group consists of several factors with putative functions in
fortifying the epithelial barrier of the gastrointestinal tract against
invasion of microorganisms. For example, the most pronounced
up-regulation was seen with the gene encoding the small proline-
rich protein 2A (Sprr2A), which was identified recently as the most
highly induced gene in a study investigating the molecular response
of a germ-free mouse gut to Bacteroides thetaiotaomicron coloni-
zation (28). Other proteins with epithelial barrier functions that are
up-regulated in Helicobacter-infected mice are CRP-ductin along
with its ligands, the trefoil peptides. The two groups of genes reflect
the immune response mounted by the infected host, which, in the
case of Helicobacter, fails to clear the infection (reviewed in ref. 29).
Having determined the signature of infected vs. uninfected
stomachs, we next sought to identify genes that discriminate be-
tween mild and moderate to severe pathology. Mice that were
uninfected andor exhibited mild pathology were grouped together
and compared with animals with moderate and severe pathology.
The 300 most differentially expressed genes (P  0.001) allowed the
complete segregation of the three major pathology groups into
three distinct arms of the dendrogram (overview in Fig. 3A), with
only three exceptions. Several representative gene clusters are
shown in Fig. 3B and selected genes are designated (the complete
gene clusters can be found in Fig. 6, which is published as supporting
information on the PNAS web site). A number of genes up-
regulated consistently in the severe pathology specimens are asso-
Fig. 2. Molecular signature of Helicobacter-
infected murine stomachs. (A) Overview of all
250 genes that are differentially regulated in
the infected vs. the uninfected animals and
have P values 0.001. Data are a measure of
relative gene expression and represent the
quotient of the hybridization of the fluores-
cent cDNA probe prepared from each stomach
sample compared with its reference pool. Red
and green represent high and low experimen-
tal samplereference ratios, respectively (see
scale bar). Gray signifies technically inade-
quate or missing data. Rows represent genes,
and columns represent arrays. An enlarged sec-
tion of the overview is shown in B. The color
coding of array names is described in Fig. 1C.
Selected genes are designated. The symbols
next to the gene names specify the laser micro-
dissection fraction (as indicated in the legend)
containing the respective transcript. See Fig. 5,
which is published as supporting information
on the PNAS web site, www.pnas.org, for the
complete cluster.
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ciated with human malignancies and can therefore be tentatively
assembled into a functional group. One example is the gene
encoding the laminin receptor-1, a protein found to be overex-
pressed on tumor cell surfaces of a variety of cancers (30) and
implicated in basement membrane degradation and tumor dissem-
ination. Another interesting gene included in this group encodes
MDR-1, a protein causally linked to the multidrug resistance of
tumors by acting as an efflux pump of chemotherapeutic agents
(31). The DNA double-strand repair protein nibrin has previously
been shown to be overexpressed in a high proportion of gastric
carcinomas (32). Its up-regulation in mice with severe pathology is
particularly interesting in light of the finding that H. pylori has been
shown to cause DNA fragmentation when cocultured with gastric
epithelial cells (33). Moreover, the chitinase-3 like protein, also
known as human cartilage glycoprotein 39, has been shown to
stimulate proliferation in human connective tissue cells and can
therefore be classified as a mitogen (34).
The described statistical approach allowed us to delineate gene
expression changes accompanying the transition from uninfected to
infected and mild to severe pathology, respectively. To test the
usefulness of the two signature gene lists for predicting the pathol-
ogy of as-yet-unclassified samples, an independent study on a
separate set of 29 animals was conducted in a blinded fashion (Fig.
3 C and D). RNA was extracted and hybridizations were performed
for this ‘‘test set’’ of mice exactly as described for the ‘‘training set.’’
Hierarchical clustering was then performed by using only the 250
and 300 genes, respectively, of the two signature gene lists (Fig. 3C;
Fig. 7, which is published as supporting information on the PNAS
web site), and pathology predictions were made based on the
resulting gene and array clustering patterns (Fig. 3D). A compar-
ison of these predictions with the independently derived pathology
data for each animal (as symbolized by the color coding in Fig. 3D)
revealed only one completely false classification (animal B1) of 29
(3.4%). As suggested earlier by the unsupervised clustering per-
formed on the training set (Fig. 1D), the gene lists do not allow for
discrimination between severe premalignant pathology and malig-
nant lymphoma, implying that the transcriptional changes between
these histologically defined grades of pathology are subtle or follow
along a continuum. Alternatively, the lack of distinguishing gene
expression between these two groups could indicate that the
classification by histology (which is currently considered the stan-
dard for MALT lymphoma diagnosis) may actually be artifactual.
As an independent method to identify genes characteristic of
distinct histopathological disease stages, we used the SAM algo-
rithm (20). SAM is based on the t test but additionally performs
permutations of the data to account for the multiple comparisons
typically complicating the statistical analysis of microarray data.
Pairwise SAM was run on groups of increasing pathology (using a
comparable false-positive discovery rate of under 5% for all three
comparisons), and genes that differ significantly between pairs are
listed in Fig. 4A. One major conclusion could be drawn using this
approach. It is apparent from the diagram shown in Fig. 4A that the
vast majority of gene expression changes occur in the two earlier
stages of the disease; they reflect the initial marked infiltration of
immune cells into the gastric mucosa and the later expansion into
the epithelium, respectively. In contrast, we find that the last step
leading to malignant transformation of the B cells and the associ-
ated destructive LELs (only those histologically classified as grade
3) is accompanied by a significant change in expression of only a
single gene encoding Mrp-8calgranulin.
Both calgranulin A and its close relative, calgranulin B, have
recently been found in a screen for phorbolester-induced genes (35,
36), thereby linking these proteins to skin carcinogenesis. Their
expression appears to be negatively regulated by c-FosAP-1 and
Fig. 3. Molecular signature of the histologically distinct stages of Helicobacter-induced lymphoproliferative disease. (A) Overview of all 300 genes that are
differentially regulated in the mild pathology vs. the moderate and severe pathology cohorts of infected animals and have P values 0.001. Five enlarged
sections are shown in B. Selected genes are designated and the color coding of array names is as described in Fig. 1C. The symbols next to the gene names specify
the laser capture fraction (as indicated in the legend) containing the respective transcript. See Fig. 6 for the complete cluster. (C and D) Predictive power of the
signature gene lists shown in Fig. 2 and A and B. Gene expression profiles were generated for an additional set of 29 animals. Arrays were clustered by using
the 250 and 300 genes constituting the signature gene lists. The dendrogram in C reflects the relatedness of all 29 specimens when the 300 gene list distinguishing
mild from moderate and severe pathology is used for clustering. The color coding of arrays is described in Fig. 1C. (D) Comparison of the pathology predictions
that were made on the basis of gene and array clustering shown in C and Fig. 7, with the results of the histopathological classification of the stomachs (as indicated
by the color coding). Only animal B1 was placed in the wrong pathology group.










transcripts localize to neutrophils and monocytes infiltrating the
inflamed skin section (36). The calgranulins are believed to func-
tion mainly in the extracellular space (reviewed in ref. 37), where
they display potent antimicrobial activity, trigger the transendothe-
lial migration of leukocytes, and induce local inflammation. The
function of the calgranulins in the transition from lymphoid hyper-
plasia to lymphoma remains to be elucidated.
To determine whether the observed changes in gene expression
occur in the mucosa itself or in the lymphocytic fraction of infected
stomachs, we isolated the respective tissues by laser microdissection.
Frozen sections of six stomachs (one uninfected and five infected;
see Fig. 4C for histopathology data on these animals) were stained
by using an abbreviated protocol that minimizes RNA degradation.
Lymphocytic aggregates were easily detected by their characteristic
size and the shape of their nuclei and could be captured virtually
free of contaminating mucosa (for micrographs of the tissue
sections before and after laser dissection, see Fig. 8, which is
published as supporting information on the PNAS web site). The
mucosal fraction was harvested in addition. RNA was extracted and
amplified in two rounds by using a T7 RNA polymerase-based
protocol (38) before labeling and hybridization. The reference
RNA was extracted from pooled age-matched control stomachs
and amplified accordingly.
Fig. 4B shows gene clusters representing parts of the lymphocytic
and mucosal signatures (Left and Right), respectively (complete
clusters can be found in Fig. 9, which is published as supporting
information on the PNAS web site). Genes that were also identified
in the whole stomach screen are marked with an asterisk. Although
the majority of genes up-regulated in the lymphocyte fractions (Fig.
4B Left) seem to be of B cell origin (specific examples being the
tyrosine kinases Btk and Syk or the Ig heavy chain), some typical
T cell markers such as the T cell receptor  and  chains, Zap70,
Lnk, the transcription factor NFATc1, and others (Fig. 4B and
supporting information on the PNAS web site) could also be
detected, thus confirming previous observations of T cells in murine
MALT tissue (14). Earlier reports have suggested that the CD4
population of T cells in human MALT tissue is Helicobacter specific
and sustains an actively proliferating B cell population by indirect
stimulation (25). Several genes found in the lymphocytic fraction
point to the presence of neutrophils in the lymphoid tissue of
infected stomachs (e.g., neutrophil cytosolic factors 2 and 4). The
neutrophilic response to Helicobacter infection, which is character-
ized by the release of potentially DNA damaging reactive oxygen
species, is believed to promote the acquisition of genetic abnor-
malities and malignant transformation of reactive B cells (25).
Among the most prevalent functional groups of genes in the
lymphocyte fraction are signaling molecules such as kinases (e.g.,
Fig. 4. (A) The diagram depicts the result of the
SAM algorithm applied pairwise to cohorts of mice
grouped according to their pathology (as indicated
in the squares). The 15 most significantly differing
genes are listed, and the gene order reflects the
significance score assigned by SAM (highest scores at
the top). (B) The cellular origin of selected tran-
scripts. Frozen tissue sections cut from stomachs of six
animals were stained and subjected to laser micro-
dissection. Both lymphocytic and mucosal fractions
were isolated from each stomach with two excep-
tions: only the mucosal fraction could be harvested
from the uninfected stomach contr15M-1, because it
did not display lymphocytic aggregation. In the case
of stomach Hh24M-5, the mucosa was so severely
destroyed and interspersed with large aggregates of
lymphocytes that no contamination-free mucosal
fraction could be obtained. The gene expression data
were filtered with respect to spot quality (spots with
regression correlations 0.6 were omitted) and data
values (genes whose log2 of redgreen normalized
ratio is more than two in at least four arrays were
selected) before clustering. Only genes for which
information was available for 80% of arrays were
included. Two representative clusters are shown:
(Left) Genes present in the lymphocytic fractions
(‘‘lymphocyte signature’’); (Right) mucosal genes
(‘‘mucosal signature’’). The gene expression pattern
for calgranulinMrp-8 is shown separately, because
it did not fall into either cluster. Genes of interest are
designated, and those genes that were also identi-
fied in the whole-stomach screen are marked with an
asterisk. The overall pathology of all six animals is
listed in C.
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the tyrosine kinases Syk, Btk, Jak3, Lck, and Csk), phosphatases
(nonreceptor type protein tyrosine phosphatases 1 and 11, hema-
topoietic cell phosphatase Hcph), small G proteins (Rac2, Rab4b,
Rab11b), and cytokines, as well as their receptors (IL2 receptor 
and  chains; IL3 receptor  chain; IL7 receptor; IL12 receptor 
chain; IL16; small inducible cytokines 13, A5, A19, and A21b; and
chemokine receptor 4). Several lymphomaleukemia related fac-
tors are also found to be expressed in the lymphocytic fraction:
examples include the Burkitt lymphoma receptor, Bcl2-A1a, Bcl2-
A1d, and Bcl6. Bcl2-A1a is of particular interest in this subgroup,
because it is most highly expressed in the two lymphoma samples
Hh24M-4 and -5 (not shown).
Among the genes up-regulated in the mucosal fractions (Fig. 4B
Right) are several that have proposed functions in the mucosal
defense against damage caused by invading pathogens. The small
proline-rich protein was identified in whole-stomach profiles (Fig.
2B) and can clearly be attributed to this functional group (28). The
trefoil factor 1 functions as a ligand for CRP-ductin and is believed
to protect the gastrointestinal epithelium from apoptosis. Another
gene involved in fortifying the epithelium is hepcidin, a short
cysteine-rich peptide displaying potent antimicrobial activity (39).
Because Mrp-8calgranulin was identified as the only marker for
severe pathology and lymphomas, its cellular origin was of partic-
ular interest. We found the transcript expressed in both the mucosal
and the lymphocytic fraction, although it is relatively more abun-
dant in the former tissue (Fig. 4B Left). Because calgranulin mainly
functions extracellularly (37), investigating the localization of the
corresponding protein will be useful in shedding light on its function
in MALT lymphoma development.
Using expression profiles generated from microdissected tissues,
every gene found to be up-regulated in the whole stomach screen
(Figs. 2B and 3B) was reexamined with regard to its cellular
localization. Symbols representing the lymphocytic and mucosal
fractions have been added to the genes shown in the respective
clusters to illustrate the likely cellular origin of these transcripts.
In an attempt to validate the laser microdissection approach by
another method, the cellular distribution of a protein encoded by
a transcript found in the lymphocytic fraction was confirmed by
immunohistochemistry on paraffin sections. The Rac-2 protein was
chosen because of its consistent and strong up-regulation early on
during lymphocytic infiltration of the stomach (Fig. 2B). It is a small
G protein and has been implicated in cell motility and consequently
cellular functions depending on cell motility, such as neutrophil
chemotaxis. This experiment confirmed that B cells in the lymphoid
aggregate indeed express Rac-2, as suggested by the laser micro-
dissection results (see Fig. 10, which is published as supporting
information on the PNAS web site).
In summary, the studies described above demonstrate that He-
licobacter-induced lymphoma develops through a series of molec-
ularly distinct stages. The transcripts that characterize particular
histopathological stages were shown to be useful in predicting the
pathology of previously unclassified specimens. In contrast to
similar studies performed on biopsies of other human malignancies,
which usually represent the end stage of the disease, our lymphoma
model provides a unique opportunity for monitoring the progres-
sion of events over time. The murine model for MALT lymphoma
is particularly useful, because it is one of the few animal tumor
models that faithfully reproduce almost all of the histological
features of the human malignancy.
A comparison of the findings of the murine model with gene
expression profiles of human MALT lymphoma biopsies may
further support the model. The human counterpart of calgranu-
lin A will be of particular interest in this respect, because it might
prove to be of predictive value for the late stages of Helicobacter-
induced lymphoproliferative disease. This and the molecular
analysis of other interesting features of the murine model system,
such as the remission of the tumor after antimicrobial therapy,
may lead to a better understanding of how a bacterial agent can
cause a human malignancy and which transcriptional changes
accompany its regression.
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